Articles with public access mandates - Ronald EllisLearn more
Not available anywhere: 4
Penetration and effectiveness of antiretroviral therapy in the central nervous system
S Letendre, RJ Ellis, B Best, A Bhatt, J Marquie-Beck, S LeBlanc, S Rossi, ...
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly …, 2009
Mandates: US National Institutes of Health
Extrapyramidal motor signs in older adults with HIV disease: frequency, 1-year course, and associations with activities of daily living and quality of life
SM Tierney, SP Woods, D Sheppard, RJ Ellis
Journal of neurovirology 25, 162-173, 2019
Mandates: US National Institutes of Health
Cognitive changes in asymptomatic drug-naive human immunodeficiency virus type 1 clade C infection
K Gopukumar, SL Rao, P Satishchandra, J Dasgupta, RJ Ellis, ...
Journal of neurovirology 14, 480-485, 2008
Mandates: US National Institutes of Health
The 21st Annual Scientific Conference of the Society on NeuroImmune Pharmacology
A Addai, J Pandhare, CV Dash
J Neuroimmune Pharmacol 10 (2), S57-S112, 2015
Mandates: US National Institutes of Health
Available somewhere: 332
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study
RK Heaton, DB Clifford, DR Franklin Jr, SP Woods, C Ake, F Vaida, ...
Neurology 75 (23), 2087-2096, 2010
Mandates: US National Institutes of Health
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors
RK Heaton, DR Franklin, RJ Ellis, JA McCutchan, SL Letendre, S LeBlanc, ...
Journal of neurovirology 17, 3-16, 2011
Mandates: US National Institutes of Health
Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial
RJ Ellis, W Toperoff, F Vaida, G Van Den Brande, J Gonzales, B Gouaux, ...
Neuropsychopharmacology 34 (3), 672-680, 2009
Mandates: US National Institutes of Health
CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy
RJ Ellis, J Badiee, F Vaida, S Letendre, RK Heaton, D Clifford, AC Collier, ...
Aids 25 (14), 1747-1751, 2011
Mandates: US National Institutes of Health
Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance
CM Marra, Y Zhao, DB Clifford, S Letendre, S Evans, K Henry, RJ Ellis, ...
Aids 23 (11), 1359-1366, 2009
Mandates: US National Institutes of Health
Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study
RK Heaton, DR Franklin Jr, R Deutsch, S Letendre, RJ Ellis, K Casaletto, ...
Clinical Infectious Diseases 60 (3), 473-480, 2015
Mandates: US National Institutes of Health
Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy
TH Burdo, MR Lentz, P Autissier, A Krishnan, E Halpern, S Letendre, ...
Journal of Infectious Diseases 204 (1), 154-163, 2011
Mandates: US National Institutes of Health
Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline
I Grant, DR Franklin Jr, R Deutsch, SP Woods, F Vaida, RJ Ellis, ...
Neurology 82 (23), 2055-2062, 2014
Mandates: US National Institutes of Health
Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life
AT Rodriguez-Penney, JE Iudicello, PK Riggs, K Doyle, RJ Ellis, ...
AIDS patient care and STDs 27 (1), 5-16, 2013
Mandates: US National Institutes of Health
Continued high prevalence and adverse clinical impact of human immunodeficiency virus–associated sensory neuropathy in the era of combination antiretroviral therapy: the …
RJ Ellis, D Rosario, DB Clifford, JC McArthur, D Simpson, T Alexander, ...
Archives of neurology 67 (5), 552-558, 2010
Mandates: US National Institutes of Health
Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy
LA Cysique, F Vaida, S Letendre, S Gibson, M Cherner, SP Woods, ...
Neurology 73 (5), 342-348, 2009
Mandates: US National Institutes of Health
Neurologic complications of HIV disease and their treatment
SL Letendre, RJ Ellis, BM Ances, JA McCutchan
Topics in HIV medicine: a publication of the International AIDS Society, USA …, 2010
Mandates: US National Institutes of Health
Inhaled cannabis for chronic neuropathic pain: a meta-analysis of individual patient data
MH Andreae, GM Carter, N Shaparin, K Suslov, RJ Ellis, MA Ware, ...
The Journal of Pain 16 (12), 1221-1232, 2015
Mandates: US National Institutes of Health
Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection
TH Burdo, A Weiffenbach, SP Woods, S Letendre, RJ Ellis, KC Williams
Aids 27 (9), 1387-1395, 2013
Mandates: US National Institutes of Health
Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort
M Smurzynski, K Wu, S Letendre, K Robertson, RJ Bosch, DB Clifford, ...
Aids 25 (3), 357-365, 2011
Mandates: US National Institutes of Health
Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy
I Everall, F Vaida, N Khanlou, D Lazzaretto, C Achim, S Letendre, ...
Journal of neurovirology 15, 360-370, 2009
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program